- Home
- PAYC vs RVMD Comparison
PAYC vs RVMD Comparison
Compare PAYC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYC
- RVMD
- Stock Information
- Founded
- PAYC 1998
- RVMD 2014
- Country
- PAYC United States
- RVMD United States
- Employees
- PAYC N/A
- RVMD N/A
- Industry
- PAYC Computer Software: Prepackaged Software
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAYC Technology
- RVMD Health Care
- Exchange
- PAYC Nasdaq
- RVMD Nasdaq
- Market Cap
- PAYC 9.1B
- RVMD 7.5B
- IPO Year
- PAYC 2014
- RVMD 2020
- Fundamental
- Price
- PAYC $163.65
- RVMD $69.14
- Analyst Decision
- PAYC Buy
- RVMD Strong Buy
- Analyst Count
- PAYC 13
- RVMD 17
- Target Price
- PAYC $225.42
- RVMD $77.24
- AVG Volume (30 Days)
- PAYC 792.2K
- RVMD 2.4M
- Earning Date
- PAYC 11-05-2025
- RVMD 11-05-2025
- Dividend Yield
- PAYC 0.91%
- RVMD N/A
- EPS Growth
- PAYC N/A
- RVMD N/A
- EPS
- PAYC 8.05
- RVMD N/A
- Revenue
- PAYC $2,001,300,000.00
- RVMD N/A
- Revenue This Year
- PAYC $10.98
- RVMD N/A
- Revenue Next Year
- PAYC $9.14
- RVMD $537.73
- P/E Ratio
- PAYC $20.39
- RVMD N/A
- Revenue Growth
- PAYC 9.72
- RVMD N/A
- 52 Week Low
- PAYC $156.50
- RVMD $29.17
- 52 Week High
- PAYC $267.76
- RVMD $69.51
- Technical
- Relative Strength Index (RSI)
- PAYC 27.65
- RVMD 82.78
- Support Level
- PAYC $162.28
- RVMD $63.50
- Resistance Level
- PAYC $171.35
- RVMD $63.15
- Average True Range (ATR)
- PAYC 6.21
- RVMD 2.47
- MACD
- PAYC -1.01
- RVMD 0.54
- Stochastic Oscillator
- PAYC 18.08
- RVMD 97.98
About PAYC Paycom Software Inc.
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.